Search research articles
Contact Us
Filters
Showing results (241-250 of 315) with videos related to
Page
of 32
Sort By:
Bone Marrow Transplantation
|
October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation
Zachariah DeFilipp, Shuli Li, David Avigan, et al.
Blood
|
September 6, 2024
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma
Katie Maurer, Isabella N Grabski, Roch Houot, et al.
Blood
|
October 4, 2018
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease
Katelyn Paz, Ryan Flynn, Jing Du, et al.
JCI Insight
|
March 3, 2022
Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation
Christopher J Severyn, Benjamin A Siranosian, Sandra Tian-Jiao Kong, et al.
Cell Reports
|
August 9, 2023
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Pavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
The New England Journal of Medicine
|
December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease
Erica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Transplantation and Cellular Therapy
|
April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
Kirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular Therapy
Katie Maurer, Cameron Y Park, Shouvik Mani, et al.
Research Square
|
April 2, 2024
Nonpathogenic <i>E. coli</i> engineered to surface display cytokines as a new platform for immunotherapy
Shaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.
Blood Advances
|
November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
Vincent T Ho, Haesook T Kim, Jennifer Brock, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 315) with videos related to
Sort By:
Page
of 32
Bone Marrow Transplantation
|
October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation
Zachariah DeFilipp, Shuli Li, David Avigan, et al.
Blood
|
September 6, 2024
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma
Katie Maurer, Isabella N Grabski, Roch Houot, et al.
Blood
|
October 4, 2018
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease
Katelyn Paz, Ryan Flynn, Jing Du, et al.
JCI Insight
|
March 3, 2022
Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation
Christopher J Severyn, Benjamin A Siranosian, Sandra Tian-Jiao Kong, et al.
Cell Reports
|
August 9, 2023
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Pavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
The New England Journal of Medicine
|
December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease
Erica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Transplantation and Cellular Therapy
|
April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
Kirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular Therapy
Katie Maurer, Cameron Y Park, Shouvik Mani, et al.
Research Square
|
April 2, 2024
Nonpathogenic <i>E. coli</i> engineered to surface display cytokines as a new platform for immunotherapy
Shaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.
Blood Advances
|
November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
Vincent T Ho, Haesook T Kim, Jennifer Brock, et al.
Page
of 32